Fas-associated factor 1 (FAF1)-loaded exosomes and use thereof as anti-cancer agent
AssigneeKainos Medicine, Inc.
InventorsEunhee Kim, Jeong-Hoon Han
Life of this patent
Estimating the term…
Loading patent…
AssigneeKainos Medicine, Inc.
InventorsEunhee Kim, Jeong-Hoon Han
Estimating the term…
Fas-associated factor 1 (FAF1) protein-loaded exosomes and a cancer treatment using FAF1 protein-loaded exosomes are disclosed. FAF1 protein-loaded exosomes are isolated from HEK 293 cells in which FAF1 having a known tumor-suppressive function is overexpressed and administered the FAF1 protein-loaded exosomes to various tumor models in which pancreatic cancer cells (MIA PaCa-2), lung cancer cells (A549), colon cancer cells (HCT 116), liver cancer cells (Hep3B), breast cancer cells (MDA-MB-231), kidney cancer cells (Caki-1) and cervical cancer cell (HeLa cell) are transplanted into nude mice through intratumoral injection. The administration exhibited tumor growth inhibitory effects remarkably greater than those of a control group not treated with FAF1.
A method for treating cancer in a subject in need thereof, the method comprising administering to the subject an effective amount of the pharmaceutical composition comprising an isolated population of FAF1 protein-loaded exosomes.
Dependencies are inferred from the claim text.